免费获得国外相关药品，最快 1 个工作日回馈药物信息
出境医 / 临床实验 / Analysis of Post-exertional Malaise Using a Two-day CPET in People With ME/CFS
Analysis of Post-exertional Malaise Using a Two-day CPET in People With ME/CFS
Study Description
Brief Summary:
This study aims to collect and identify key outcome measures or disease parameters in ME/CFS that are altered during elevated symptoms relative to baseline by gathering information before and after symptom provocation using a two-day cardiopulmonary exercise test.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Myalgic Encephalomyelitis Chronic Fatigue Syndrome | Other: Two-day cardiopulmonary exercise test | Not Applicable |
Detailed Description:
The phenomenon of post-exertional malaise (PEM), in which an ME/CFS patient's symptoms are elevated following even low-level exertion, is a hallmark feature of the disease. The cause of PEM, like the cause of ME/CFS, is not understood. This study aims to utilize a two-day CPET to invoke PEM. This provides a unique opportunity to collect data on how key outcome measures or disease parameters are altered during elevated symptoms relative to baseline within each patient by gathering information before and after symptom provocation.
A total of 90 participants and 90 controls will undergo CPET testing. Participation will be split amongst three different sites (Ithaca, NY, New York, NY, and Los Angeles, CA). Subjects will be located in urban and rural areas to establish relatively diverse study populations.
This study is a component of the Cornell ME/CFS Collaborative Research Center (CRC). Blood samples taken before and after CPET will be utilized in associated projects with the Cornell ME/CFS CRC. CPET data along with the analysis of blood samples has great potential to reveal why exercise negatively affects ME/CFS patients and thus perhaps why patients are also impaired even before increasing their activity level.
Study Design
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 180 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Probing Metabolism, Circulating Inflammatory Molecules, Extracellular Vesicles and Immune Dysregulation in Individual Immune Cells in ME/CFS |
| Actual Study Start Date : | August 1, 2018 |
| Estimated Primary Completion Date : | August 31, 2021 |
| Estimated Study Completion Date : | August 31, 2022 |
Arms and Interventions
| Arm | Intervention/treatment |
|---|---|
|
Experimental: ME/CFS
Adults with ME/CFS
|
Other: Two-day cardiopulmonary exercise test
A series of two cardiopulmonary exercise tests (CPETs) performed over two days. Participants will perform a CPET and then will return approximately 24 hours later to perform the second CPET. The CPET begins with 3 minutes of seated rest followed by cycling during incremental workloads which increases 15 watts throughout each minute of exercise. The participant will cycle until volitional exhaustion and/or the participant and/or test administrator determines to stop the test. Actual exercise time usually varies between 8-10 minutes.
|
|
Active Comparator: Healthy controls
Healthy, low-active adults
|
Other: Two-day cardiopulmonary exercise test
A series of two cardiopulmonary exercise tests (CPETs) performed over two days. Participants will perform a CPET and then will return approximately 24 hours later to perform the second CPET. The CPET begins with 3 minutes of seated rest followed by cycling during incremental workloads which increases 15 watts throughout each minute of exercise. The participant will cycle until volitional exhaustion and/or the participant and/or test administrator determines to stop the test. Actual exercise time usually varies between 8-10 minutes.
|
Outcome Measures
Primary Outcome Measures :
- Volume of oxygen consumed at peak effort [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Volume of oxygen consumed at peak effort during CPET 1 and during CPET 2.
- Volume of oxygen consumed at ventilatory/anaerobic threshold (VAT) [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]VAT is a non-invasive surrogate measure for anaerobic threshold, which is indicated during incremental exercise by a non-linear increase in rate of carbon dioxide production relative to rate of oxygen consumption.
- Rate of work performed at peak effort [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Rate of work performed at peak effort during CPET 1 and during CPET 2. Rate of work is measured in Watts.
- Rate of work performed at VAT [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Rate of work performed at VAT during CPET 1 and during CPET 2. Rate of work is measured in Watts.
- Heart rate at peak effort [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Heart rate at peak effort during CPET 1 and during CPET 2.
- Heart rate at VAT [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Heart rate at VAT during CPET 1 and during CPET 2.
- Systolic blood pressure at seated rest [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Systolic blood pressure at seated rest 1-minute before the start of CPET 1 and 1-minute before the start of CPET 2.
- Systolic blood pressure at peak effort [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]Systolic blood pressure at peak effort during CPET 1 and during CPET 2.
- Respiratory Exchange Ratio (RER) at peak effort [ Time Frame: During intervention on day 1 and during intervention on day 2; assessed through study completion, approximately 4 years from study start date. ]RER at peak effort during CPET 1 and during CPET 2. RER is calculated as the rate of carbon dioxide production divided by the rate of oxygen consumption, and during exercise is an indicator of participant effort.
Eligibility Criteria
| Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Adults with ME/CFS:
Inclusion Criteria:
- Diagnosed with ME/CFS
- Adults 18 to 70 years of age
Exclusion Criteria:
- Recent history of panic attacks within the past 6 months
- Diagnosis of schizophrenia, major depressive disorder, bipolar disorder, or an anxiety disorder such as OCD or PTSD
- Hospitalized for a psychological condition within the last 6 months
- Unwilling to stop taking nutritional supplements, including probiotics, two weeks before the exercise tests.
- Unwilling to stop pain medication and stimulant medication two days before the exercise tests.
- Smoker, or stopped smoking less than 1 year ago
- Pregnant or breastfeeding
- Diabetic
- Have an orthopedic limitation that prohibits cycle exercise
- Excessive alcohol consumption
Healthy Volunteers:
Inclusion Criteria:
- Healthy
- Low-active
- Adults 18 to 70 years of age
Exclusion Criteria:
- Recent history of panic attacks within the past 6 months
- Diagnosis of schizophrenia, major depressive disorder, bipolar disorder, or an anxiety disorder such as OCD or PTSD
- Hospitalized for a psychological condition within the last 6 months
- Unwilling to stop taking nutritional supplements, including probiotics, two weeks before the exercise tests.
- Unwilling to stop pain medication and stimulant medication two days before the exercise tests.
- Smoker, or stopped smoking less than 1 year ago
- Pregnant or breastfeeding
- Diabetic
- Have an orthopedic limitation that prohibits cycle exercise
- Excessive alcohol consumption
Contacts and Locations
Locations
| United States, California | |
| ID Med | Recruiting |
| Torrance, California, United States, 90505 | |
| Contact: Jared Stevens, B.S. 209-599-7194 info@workwellfoundation.org | |
| United States, New York | |
| Ithaca College | Active, not recruiting |
| Ithaca, New York, United States, 14850 | |
| Weill Cornell Medicine | Recruiting |
| New York, New York, United States, 10021 | |
| Contact: Xiangling Mao, M.S. 212-746-2632 xim2004@med.cornell.edu | |
Sponsors and Collaborators
Ithaca College
Cornell University
Weill Medical College of Cornell University
Workwell Foundation
Investigators
| Study Director: | Betsy Keller, Ph.D. | Ithaca College | |
| Study Director: | Geoff Moore, M.D. | Ithaca College |
| Tracking Information | |||||||
|---|---|---|---|---|---|---|---|
| First Submitted Date ICMJE | July 2, 2019 | ||||||
| First Posted Date ICMJE | July 19, 2019 | ||||||
| Last Update Posted Date | February 17, 2021 | ||||||
| Actual Study Start Date ICMJE | August 1, 2018 | ||||||
| Estimated Primary Completion Date | August 31, 2021 (Final data collection date for primary outcome measure) | ||||||
| Current Primary Outcome Measures ICMJE |
|
||||||
| Original Primary Outcome Measures ICMJE |
|
||||||
| Change History | |||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||||
| Descriptive Information | |||||||
| Brief Title ICMJE | Analysis of Post-exertional Malaise Using a Two-day CPET in People With ME/CFS | ||||||
| Official Title ICMJE | Probing Metabolism, Circulating Inflammatory Molecules, Extracellular Vesicles and Immune Dysregulation in Individual Immune Cells in ME/CFS | ||||||
| Brief Summary | This study aims to collect and identify key outcome measures or disease parameters in ME/CFS that are altered during elevated symptoms relative to baseline by gathering information before and after symptom provocation using a two-day cardiopulmonary exercise test. | ||||||
| Detailed Description |
The phenomenon of post-exertional malaise (PEM), in which an ME/CFS patient's symptoms are elevated following even low-level exertion, is a hallmark feature of the disease. The cause of PEM, like the cause of ME/CFS, is not understood. This study aims to utilize a two-day CPET to invoke PEM. This provides a unique opportunity to collect data on how key outcome measures or disease parameters are altered during elevated symptoms relative to baseline within each patient by gathering information before and after symptom provocation. A total of 90 participants and 90 controls will undergo CPET testing. Participation will be split amongst three different sites (Ithaca, NY, New York, NY, and Los Angeles, CA). Subjects will be located in urban and rural areas to establish relatively diverse study populations. This study is a component of the Cornell ME/CFS Collaborative Research Center (CRC). Blood samples taken before and after CPET will be utilized in associated projects with the Cornell ME/CFS CRC. CPET data along with the analysis of blood samples has great potential to reveal why exercise negatively affects ME/CFS patients and thus perhaps why patients are also impaired even before increasing their activity level. |
||||||
| Study Type ICMJE | Interventional | ||||||
| Study Phase ICMJE | Not Applicable | ||||||
| Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Basic Science |
||||||
| Condition ICMJE |
|
||||||
| Intervention ICMJE | Other: Two-day cardiopulmonary exercise test
A series of two cardiopulmonary exercise tests (CPETs) performed over two days. Participants will perform a CPET and then will return approximately 24 hours later to perform the second CPET. The CPET begins with 3 minutes of seated rest followed by cycling during incremental workloads which increases 15 watts throughout each minute of exercise. The participant will cycle until volitional exhaustion and/or the participant and/or test administrator determines to stop the test. Actual exercise time usually varies between 8-10 minutes.
|
||||||
| Study Arms ICMJE |
|
||||||
| Publications * | Not Provided | ||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||
| Recruitment Information | |||||||
| Recruitment Status ICMJE | Recruiting | ||||||
| Estimated Enrollment ICMJE |
180 | ||||||
| Original Estimated Enrollment ICMJE | Same as current | ||||||
| Estimated Study Completion Date ICMJE | August 31, 2022 | ||||||
| Estimated Primary Completion Date | August 31, 2021 (Final data collection date for primary outcome measure) | ||||||
| Eligibility Criteria ICMJE |
Adults with ME/CFS: Inclusion Criteria:
Exclusion Criteria:
Healthy Volunteers: Inclusion Criteria:
Exclusion Criteria:
|
||||||
| Sex/Gender ICMJE |
|
||||||
| Ages ICMJE | 18 Years to 70 Years (Adult, Older Adult) | ||||||
| Accepts Healthy Volunteers ICMJE | Yes | ||||||
| Contacts ICMJE | |||||||
| Listed Location Countries ICMJE | United States | ||||||
| Removed Location Countries | |||||||
| Administrative Information | |||||||
| NCT Number ICMJE | NCT04026425 | ||||||
| Other Study ID Numbers ICMJE |
U54NS105541( U.S. NIH Grant/Contract ) 5U54NS105541 ( U.S. NIH Grant/Contract ) |
||||||
| Has Data Monitoring Committee | No | ||||||
| U.S. FDA-regulated Product |
|
||||||
| IPD Sharing Statement ICMJE | Not Provided | ||||||
| Responsible Party | Ithaca College | ||||||
| Study Sponsor ICMJE | Ithaca College | ||||||
| Collaborators ICMJE |
|
||||||
| Investigators ICMJE |
|
||||||
| PRS Account | Ithaca College | ||||||
| Verification Date | February 2021 | ||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||
